A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)
PHASE2
This is a prospective randomized controlled Phase Ⅱ/Ⅲ Clinical study to eva...
Status
Not Yet Recruiting
Location
Medical Oncology,Sun Yat-sen University Cancer Center
The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer
PHASE2
Colorectal cancer is a malignant tumor ranking among the top four in incide...
Status
Recruiting
Location
Second Affiliated Hospital Zhejiang University College of Medicine, Hangzhou, Zhejiang Province 310999
The Efficacy and Safety of IBI351, Cetuximab β Combined With FOLFIRI as First-line /IBI351, Cetuximab β as Second-line in the Treatment of KRAS G12C-mutated Metastatic Colorectal Cancer
PHASE2
This is an open-label, multicenter, single-arm Phase II clinical study, div...
Status
Enrolling By Invitation
Location
The Second Affiliated Hospital, School of Medicine, Zhejiang University